These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 568029)

  • 21. Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
    Goss PE; Powles TJ; Dowsett M; Hutchison G; Brodie AM; Gazet JC; Coombes RC
    Cancer Res; 1986 Sep; 46(9):4823-6. PubMed ID: 2942241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women.
    Lebrun CE; van der Schouw YT; de Jong FH; Pols HA; Grobbee DE; Lamberts SW
    Maturitas; 2006 Aug; 55(1):82-92. PubMed ID: 16497451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.
    Barrett-Connor E; Garland C; McPhillips JB; Khaw KT; Wingard DL
    Cancer Res; 1990 Jan; 50(1):169-73. PubMed ID: 2293551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of peripheral aromatization in postmenopausal women with breast cancer.
    Barone RM; Judd HL
    Surg Forum; 1978; 29():172-4. PubMed ID: 401126
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo effects of delta 1-testololactone on peripheral aromatization.
    Judd HL; Barone RM; Laufer LR; Gambone JC; Monfort SL; Lasley BL
    Cancer Res; 1982 Aug; 42(8 Suppl):3345s-3348s. PubMed ID: 7083208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between ovarian production of estrone, estradiol, testosterone, and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women.
    Sluijmer AV; Heineman MJ; Koudstaal J; Theunissen PH; de Jong FH; Evers JL
    Menopause; 1998; 5(4):207-10. PubMed ID: 9872485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
    Schairer C; Hill D; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1660-5. PubMed ID: 16030098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
    Dowsett M; Lal A; Smith IE; Jeffcoate SL
    Br J Cancer; 1987 Mar; 55(3):311-3. PubMed ID: 2952154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
    Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
    Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.
    Harris AL; Cantwell BM; Dowsett M
    Br J Cancer; 1988 Oct; 58(4):493-6. PubMed ID: 2974717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women.
    Friedenreich CM; Woolcott CG; McTiernan A; Ballard-Barbash R; Brant RF; Stanczyk FZ; Terry T; Boyd NF; Yaffe MJ; Irwin ML; Jones CA; Yasui Y; Campbell KL; McNeely ML; Karvinen KH; Wang Q; Courneya KS
    J Clin Oncol; 2010 Mar; 28(9):1458-66. PubMed ID: 20159820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability and interrelations among serum sex hormones in postmenopausal women.
    Cauley JA; Gutai JP; Kuller LH; Powell JG
    Am J Epidemiol; 1991 Jan; 133(1):50-7. PubMed ID: 1983898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total and free estrogens and androgens in postmenopausal women with hip fractures.
    Davidson BJ; Ross RK; Paganini-Hill A; Hammond GD; Siiteri PK; Judd HL
    J Clin Endocrinol Metab; 1982 Jan; 54(1):115-20. PubMed ID: 7198650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone.
    Barone RM; Shamonki IM; Siiteri PK; Judd HL
    J Clin Endocrinol Metab; 1979 Nov; 49(5):672-6. PubMed ID: 489709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients.
    Poortman J; Thijssen JH; Schwarz F
    J Clin Endocrinol Metab; 1973 Jul; 37(1):101-9. PubMed ID: 4268455
    [No Abstract]   [Full Text] [Related]  

  • 38. Androstenedione metabolism in patients with endometrial cancer.
    Calanog A; Sall S; Gordon GG; Southren AL
    Am J Obstet Gynecol; 1977 Nov; 129(5):553-6. PubMed ID: 910844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and androgen levels in women treated with radiation for cervical cancer--possible influence on breast cancer risk.
    Eby NL; Boice JD; Gold EB; Hoover RN; Loriaux DL
    Am J Epidemiol; 1989 Mar; 129(3):527-32. PubMed ID: 2783832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen and estrogen dynamics in pre- and postmenopausal women: a comparison between smokers and nonsmokers.
    Longcope C; Johnston CC
    J Clin Endocrinol Metab; 1988 Aug; 67(2):379-83. PubMed ID: 3392163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.